URL has been copied successfully!
Why does it take a new drug 10 years, on average, to come to market? Part of the reason lies in the dead time in the process.
Historically, trials have required tedious tabulations and repeated application submissions between phases, which is why 45% of the time from a Phase 1 trial until final submission is spent without any ongoing clinical trial in progress — idle time in the system.
Please follow us:
